Retatrutide in Australia: A Promising Hope for Obesity Management ?
Australia is eagerly anticipating the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a potential advance in obesity treatment . Early clinical trials have demonstrated impressive results, showing greater effectiveness than existing treatments like semaglutid